Intragastric balloons have gained significant attention in the field of weight loss management. This non-surgical procedure involves the insertion of a balloon into the stomach, which occupies space and promotes satiety, leading to weight loss. The intragastric balloon serves as a temporary solution for individuals looking to shed excess pounds without undergoing invasive surgeries such as gastric bypass or sleeve gastrectomy.
The global intragastric balloon market is expected to experience substantial growth in the coming years. Several factors contribute to this growth including the rising prevalence of obesity worldwide and the increasing demand for minimally invasive weight loss procedures. Additionally, the growing awareness about the long-term health risks associated with obesity is driving individuals to seek effective weight management solutions.
However, there are certain restraints that could impede the market growth. Adverse events, such as balloon deflation or migration, gastric ulcers, and gastrointestinal obstructions, have been reported in some cases, which might deter potential patients from opting for this procedure. Moreover, the high cost of intragastric balloon treatment and the lack of reimbursement options in some regions pose challenges for market penetration.
Despite these restraints, the market presents several opportunities for growth. Technological advancements in balloon design and materials, such as the introduction of adjustable balloons and self-sealing valves, offer improved patient outcomes and enhanced safety profiles. Moreover, the growing adoption of intragastric balloons in emerging markets provides significant opportunities for market expansion. For instance, in March 2023, Pristyn Care, a healthcare provider, collaborated with Allurion Technologies, a medical device company to introduce a comprehensive solution which is intragastric balloon for weight loss and obesity management. This innovative program introduces the world's first ingestible gastric balloon, eliminating the need for surgery, endoscopy, or anesthesia. The primary goal of the program is to assist patients in shedding approximately 10 to 15% of their body weight over a 16-week treatment period. As a result of the growing popularity of minimally invasive treatments and supportive initiatives, significant market expansion is anticipated.
Key Features of the Study:
Intragastric Balloon Market Segmentation:
Table of Contents
*Browse 44 market data tables and 31 figures on "Intragastric Balloon Market” - Global forecast to 2030